A detailed history of Private Advisor Group, LLC transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Private Advisor Group, LLC holds 26,104 shares of TEVA stock, worth $446,639. This represents 0.0% of its overall portfolio holdings.

Number of Shares
26,104
Previous 23,114 12.94%
Holding current value
$446,639
Previous $375,000 25.33%
% of portfolio
0.0%
Previous 0.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 22, 2024

BUY
$15.81 - $18.96 $47,271 - $56,690
2,990 Added 12.94%
26,104 $470,000
Q2 2024

Aug 05, 2024

BUY
$12.78 - $17.4 $13,968 - $19,018
1,093 Added 4.96%
23,114 $375,000
Q1 2024

Apr 30, 2024

BUY
$10.67 - $14.43 $27,709 - $37,474
2,597 Added 13.37%
22,021 $310,000
Q4 2023

Feb 06, 2024

BUY
$8.12 - $10.63 $37,790 - $49,472
4,654 Added 31.51%
19,424 $202,000
Q3 2023

Nov 02, 2023

BUY
$7.48 - $10.7 $13,389 - $19,153
1,790 Added 13.79%
14,770 $150,000
Q2 2023

Aug 09, 2023

SELL
$7.2 - $9.47 $1,440 - $1,894
-200 Reduced 1.52%
12,980 $97,000
Q4 2022

Jan 18, 2023

SELL
$7.95 - $9.48 $9,754 - $11,631
-1,227 Reduced 8.52%
13,180 $0
Q3 2022

Oct 14, 2022

SELL
$6.86 - $11.95 $70,390 - $122,618
-10,261 Reduced 41.6%
14,407 $116,000
Q2 2022

Jul 13, 2022

BUY
$7.38 - $10.4 $80,080 - $112,850
10,851 Added 78.53%
24,668 $185,000
Q1 2022

May 12, 2022

SELL
$7.33 - $9.39 $9,748 - $12,488
-1,330 Reduced 8.78%
13,817 $130,000
Q4 2021

Feb 10, 2022

SELL
$7.9 - $10.19 $9,440 - $12,177
-1,195 Reduced 7.31%
15,147 $121,000
Q3 2021

Oct 14, 2021

SELL
$8.38 - $10.18 $175 - $213
-21 Reduced 0.13%
16,342 $159,000
Q2 2021

Aug 12, 2021

BUY
$9.9 - $11.56 $5,791 - $6,762
585 Added 3.71%
16,363 $162,000
Q1 2021

Apr 22, 2021

SELL
$10.34 - $12.81 $30,058 - $37,238
-2,907 Reduced 15.56%
15,778 $182,000
Q4 2020

Apr 01, 2021

SELL
$8.61 - $11.04 $2,789 - $3,576
-324 Reduced 1.7%
18,685 $180,000
Q3 2020

Nov 02, 2020

SELL
$8.57 - $12.69 $25,350 - $37,537
-2,958 Reduced 13.47%
19,009 $171,000
Q2 2020

Aug 17, 2020

BUY
$8.12 - $13.12 $18,497 - $29,887
2,278 Added 11.57%
21,967 $271,000
Q1 2020

May 12, 2020

BUY
$6.69 - $13.45 $4,335 - $8,715
648 Added 3.4%
19,689 $177,000
Q4 2019

Feb 10, 2020

SELL
$6.53 - $10.72 $92,229 - $151,409
-14,124 Reduced 42.59%
19,041 $187,000
Q3 2019

Nov 13, 2019

BUY
$6.16 - $9.6 $54,528 - $84,979
8,852 Added 36.41%
33,165 $156,000
Q2 2019

Aug 14, 2019

SELL
$8.12 - $15.72 $80,720 - $156,272
-9,941 Reduced 29.02%
24,313 $223,000
Q1 2019

May 13, 2019

SELL
$15.58 - $20.01 $72,727 - $93,406
-4,668 Reduced 11.99%
34,254 $536,000
Q4 2018

Feb 11, 2019

BUY
$14.59 - $23.84 $79,748 - $130,309
5,466 Added 16.34%
38,922 $600,000
Q3 2018

Nov 01, 2018

BUY
$21.06 - $25.65 $528,584 - $643,789
25,099 Added 300.34%
33,456 $721,000
Q2 2018

Aug 09, 2018

SELL
$16.77 - $24.71 $220,626 - $325,084
-13,156 Reduced 61.15%
8,357 $204,000
Q1 2018

May 09, 2018

BUY
$16.68 - $22.07 $358,836 - $474,791
21,513 New
21,513 $368,000
Q4 2017

Feb 07, 2018

SELL
$11.23 - $19.1 $246,307 - $418,920
-21,933 Closed
0 $0
Q3 2017

Nov 13, 2017

BUY
$15.41 - $32.17 $161,666 - $337,495
10,491 Added 91.69%
21,933 $347,000
Q2 2017

Aug 10, 2017

BUY
N/A
11,442
11,442 $357,000

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $19B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Private Advisor Group, LLC Portfolio

Follow Private Advisor Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Private Advisor Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Private Advisor Group, LLC with notifications on news.